Erenumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Erenumab and local guidelines before prescribing.

CGRP antagonist

Mechanism

CGRP receptor monoclonal antibody.

Uses

Migraine prophylaxis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Constipation, hypertension, injection-site reactions.

Interactions

Few.

Contraindications and cautions

Uncontrolled hypertension

Monitoring

BP

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Monitor BP; constipation can be severe.

More from the textbook: uses, cautions and other points
Where it is discussed in the book